What neuroenhancement really improves – and what only works subjectively better. Those who use cognitive performance-enhancing substances particularly frequently. Between Ritalin, Modafinil and coffee, the line between therapy and optimization is blurred. The article classifies prevalences, motivations and risks, explains the mechanisms of action of the most important substance classes and shows why the benefits are often overestimated, with practical tips for medical education in everyday life.
Autoren
- Dr. Ulf Blanke
Publikation
- InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
You May Also Like
- Proteins in wound healing
Do special amino acids lead to success?
- Case study
Autosomal recessive polycystic kidney disease: atypical phenotype
- Current evidence, risk classes and new counseling options
Hormonal contraception and cardiovascular risk
- Acute otitis media: self-limiting course vs. "red flags"
In which cases are antibiotics necessary?
- Prurigo nodularis: evidence-based treatment
Targeted therapy options on the rise
- MACE risk, heart failure incidence and all-cause mortality
Metabolic syndrome as a cardiovascular risk factor
- Glaucoma in old age: slowing down progression
IOP lowering is currently the only evidence-based treatment
- Vector-borne infections with skin manifestations